These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 31461880

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
    Fields GB.
    Front Immunol; 2019; 10():1278. PubMed ID: 31214203
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
    Bhowmick M, Stawikowska R, Tokmina-Roszyk D, Fields GB.
    Chembiochem; 2015 May 04; 16(7):1084-92. PubMed ID: 25766890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
    Gentile E, Liuzzi GM.
    Drug Discov Today; 2017 Feb 04; 22(2):299-313. PubMed ID: 27697495
    [Abstract] [Full Text] [Related]

  • 7. Development of High Affinity and High Specificity Inhibitors of Matrix Metalloproteinase 14 through Computational Design and Directed Evolution.
    Arkadash V, Yosef G, Shirian J, Cohen I, Horev Y, Grossman M, Sagi I, Radisky ES, Shifman JM, Papo N.
    J Biol Chem; 2017 Feb 24; 292(8):3481-3495. PubMed ID: 28087697
    [Abstract] [Full Text] [Related]

  • 8. Understanding the variability of the S1' pocket to improve matrix metalloproteinase inhibitor selectivity profiles.
    Gimeno A, Beltrán-Debón R, Mulero M, Pujadas G, Garcia-Vallvé S.
    Drug Discov Today; 2020 Jan 24; 25(1):38-57. PubMed ID: 31513929
    [Abstract] [Full Text] [Related]

  • 9. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
    Skiles JW, Gonnella NC, Jeng AY.
    Curr Med Chem; 2004 Nov 24; 11(22):2911-77. PubMed ID: 15544483
    [Abstract] [Full Text] [Related]

  • 10. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J, Khalil RA.
    Prog Mol Biol Transl Sci; 2017 Nov 24; 148():355-420. PubMed ID: 28662828
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
    Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T.
    Eur J Med Chem; 2020 May 15; 194():112260. PubMed ID: 32224379
    [Abstract] [Full Text] [Related]

  • 12. Recent opportunities in matrix metalloproteinase inhibitor drug design for cancer.
    Zhong Y, Lu YT, Sun Y, Shi ZH, Li NG, Tang YP, Duan JA.
    Expert Opin Drug Discov; 2018 Jan 15; 13(1):75-87. PubMed ID: 29088927
    [Abstract] [Full Text] [Related]

  • 13. The Roles of Matrix Metalloproteinases in Pancreatic Cancer.
    Knapinska AM, Estrada CA, Fields GB.
    Prog Mol Biol Transl Sci; 2017 Jan 15; 148():339-354. PubMed ID: 28662827
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11.
    Knapinska AM, Hart M, Drotleff G, Fields GB.
    Molecules; 2019 Nov 28; 24(23):. PubMed ID: 31795279
    [Abstract] [Full Text] [Related]

  • 16. Validation of Matrix Metalloproteinase-9 (MMP-9) as a Novel Target for Treatment of Diabetic Foot Ulcers in Humans and Discovery of a Potent and Selective Small-Molecule MMP-9 Inhibitor That Accelerates Healing.
    Nguyen TT, Ding D, Wolter WR, Pérez RL, Champion MM, Mahasenan KV, Hesek D, Lee M, Schroeder VA, Jones JI, Lastochkin E, Rose MK, Peterson CE, Suckow MA, Mobashery S, Chang M.
    J Med Chem; 2018 Oct 11; 61(19):8825-8837. PubMed ID: 30212201
    [Abstract] [Full Text] [Related]

  • 17. Novel Matrix Metalloproteinase-9 (MMP-9) Inhibitors in Cancer Treatment.
    Rashid ZA, Bardaweel SK.
    Int J Mol Sci; 2023 Jul 28; 24(15):. PubMed ID: 37569509
    [Abstract] [Full Text] [Related]

  • 18. Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.
    Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P.
    Bioorg Med Chem; 2013 Nov 01; 21(21):6456-65. PubMed ID: 24071448
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
    Creemers EE, Cleutjens JP, Smits JF, Daemen MJ.
    Circ Res; 2001 Aug 03; 89(3):201-10. PubMed ID: 11485970
    [Abstract] [Full Text] [Related]

  • 20. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
    Skiles JW, Gonnella NC, Jeng AY.
    Curr Med Chem; 2001 Mar 03; 8(4):425-74. PubMed ID: 11172697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.